A method for producing wild yak sperm using a male yak sterility model and its application.
By utilizing the male yak infertility model and stem cell technology, an in vivo spermatogenesis platform for reproductive cells without altering the genetic background was established, solving the technical challenges in the protection of rare wild animal germplasm resources and achieving efficient and sustainable sperm production.
Patent Information
- Application Number
- CN202611294938.8
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2026-08-25
- Publication Date
- 2026-11-17
AI Technical Summary
Current technologies lack an in vivo spermatogenesis platform that does not alter the recipient's genetic background, is easy to operate, and has low regulatory risks in the protection of rare and endangered wildlife germplasm resources. Traditional semen collection and frozen sperm preservation methods have shortcomings, and existing methods such as gene editing and chemical ablation have defects.
Using a natural sterility model of male yak, an in vivo spermatogenesis platform for germ cells without gene editing was established through the injection and chimerism of spermatogonial stem cells and pluripotent stem cells. Male yak sterile recipients were screened and injected to obtain wild yak donor sperm.
This enables a spermatogenesis process that does not require gene editing, improving success rates and reproducibility, reducing reliance on field capture and semen cryopreservation, and providing a sustainable method for live sperm production.
Smart Images

Figure CN123107915A_ABST
Abstract
Description
Technical Field
[0001] This invention relates to the field of animal reproductive biotechnology, and in particular to a method for producing wild yak sperm using a male yak sterility model and its application. Background Technology
[0002] Wild yak (Bos grunniens) is a large wild bovine species endemic to the Qinghai-Tibet Plateau. It possesses excellent genetic traits such as tolerance to high altitudes and low oxygen levels, and the ability to thrive on roughage, making it an important germplasm resource for yak genetic improvement. However, wild yaks are difficult to capture due to their unique distribution. Traditional germplasm conservation methods, relying on semen collection and cryopreservation, suffer from problems such as limited semen collection opportunities, significant fluctuations in semen quality, freeze-thaw damage, and high costs associated with long-term liquid nitrogen preservation. Therefore, there is an urgent need to develop new germplasm resource preservation and propagation technologies.
[0003] Spermatogonial stem cells (SSCs) possess the ability to self-renew and differentiate into sperm. Transplanting donor SSCs into the testes of infertile recipients, allowing them to colonize in the seminiferous tubules and complete spermatogenesis, represents a potential pathway for the propagation of rare animal germplasm. Currently, the main methods for establishing infertile recipient models include: (1) Chemical ablation (such as busulfan treatment) has problems with drug toxicity and non-specific damage; (2) Irradiation treatment is complex to operate and can easily cause irreversible tissue damage; (3) Gene editing (such as knocking out key spermatogenic genes such as NANOS2 and DAZL), although highly specific, faces problems such as off-target effects, alteration of genetic background, ethical controversies, and long regulatory approval cycles. None of the above methods are suitable for direct use in the protection of rare and endangered wildlife germplasm resources.
[0004] Embryonic chimerism is another technological approach—injecting donor pluripotent stem cells into early recipient embryos, allowing the donor cells to participate in embryonic development and selectively compensate for specific cell lineages. However, current embryonic chimerism techniques also rely on gene editing of the recipient embryo to produce developmental defects.
[0005] Hybrid cattle are the offspring of yaks and ordinary cattle. Male hybrid yaks generally exhibit male infertility: their testicular germ cells development is arrested at the spermatogonial or primary spermatocyte stage, but the Sertoli cells, interstitial cells, and seminiferous tubules are relatively intact, and the endocrine environment is normal. This makes them naturally possess the potential to serve as recipients of heterologous donor germ cells for in vivo spermatogenesis. However, current technologies only use hybrid cattle as the research object of infertility mechanism, and there has never been a technical solution to use their infertility phenotype as a tool for heterologous donor spermatogenesis.
[0006] In summary, the existing technology has the following problems: (1) Construct active intervention methods such as infertility receptor-dependent gene editing, chemical ablation, or irradiation; (2) There is a lack of in vivo spermatogenesis platforms that do not alter the genetic background of the recipient, are easy to operate, and have low regulatory risks in the protection of rare and endangered wild animal germplasm. (3) The preservation of wild yak germplasm resources relies excessively on semen cryopreservation and lacks sustainable live sperm production technology.
[0007] Therefore, there is an urgent need to design a method for producing wild yak sperm using a male yak sterility model. Summary of the Invention
[0008] This invention provides a method for producing wild yak sperm using a male yak sterility model and its application.
[0009] A method for producing wild yak sperm using a male yak sterility model includes the following steps: Through semen analysis, testicular ultrasound, reproductive hormone testing, and testicular biopsy, male yak were screened for endogenous germ cell development arrest and for intact seminiferous tubule basement membrane, Sertoli cells, and interstitial cells to obtain male yak infertility recipients, and wild yak donor spermatogonial stem cells and wild yak donor pluripotent stem cells were prepared. The wild yak donor spermatogonial stem cells were injected into the testes of the male yak infertile recipient to obtain a transplanted male yak recipient; the wild yak donor pluripotent stem cells were injected into early yak embryos, and male chimeras were obtained through culture and embryo transfer. Semen was collected from the transplanted male yak recipient and male chimera. The donor source of the sperm was identified using STR markers and wild yak Y chromosome-specific markers, thus obtaining sperm from wild yak donors.
[0010] As a further technical solution of the present invention, the screening of male yak infertility recipients includes: Male yaks aged 12–60 months, in good condition and free from infectious diseases were selected, and two semen analyses were performed at intervals of 7–30 days to screen for individuals with azoospermia or sperm density less than 1×10^6 / mL. The individuals underwent testicular ultrasound, reproductive hormone testing, and testicular biopsy to screen for individuals with intact seminiferous tubule basement membranes, presence of Sertoli cells and interstitial cells, a significant reduction in endogenous germ cells or arrest at the spermatogonial or primary spermatocyte stage, and no extensive fibrosis.
[0011] As a further technical solution of the present invention, the preparation of the wild yak donor spermatogonial stem cells includes: After removing the capsule and blood vessels from the testicular tissue of wild yak, the seminiferous tubules were cut into small pieces and digested in two steps, successively with digestion solutions containing collagenase IV and DNase I, and digestion solutions containing trypsin and hyaluronidase. The resulting single-cell suspension was filtered. Spermatogonia were enriched using one or more of the following methods: differential adhesion, Percoll density gradient centrifugation, immunomagnetic bead sorting, or flow cytometry. The suspension was then expanded in a short period of time, and cells with a viability of 85% were selected for transplantation.
[0012] As a further technical solution of the present invention, the wild yak donor spermatogonial stem cells are resuspended in a transplantation buffer containing 0.04% trypan blue, and the cell concentration is adjusted to 5×10^7 cells / mL. The cells are then introduced into the testes of the male yak infertile recipient by injection into the testis reticulum, injection into the efferent canaliculus, or ultrasound-guided multi-point injection into the testis parenchyma. The injection volume for testicular reticulum injection is 0.5–1 mL per side. For ultrasound-guided multi-point injection of testicular parenchyma, 3–5 injection points are set on each side, and 50–200 μL is injected at each injection point.
[0013] As a further technical solution of the present invention, testicular ultrasound, semen collection and analysis, donor cell tracking, and serum testosterone, luteinizing hormone and follicle-stimulating hormone tests are performed on the male yak recipient after transplantation at 1 week, 1 month, 3 months, 6 months and every 3 months thereafter.
[0014] As a further technical solution of the present invention, the wild yak donor pluripotent stem cells are embryonic stem cells or induced pluripotent stem cells; the embryonic stem cells are obtained by removing the zona pellucida of wild yak cloned blastocysts on days 7 to 9, inoculating them onto feeder cells, culturing them, dissociating the proliferators, and re-inoculating them. The induced pluripotent stem cells were obtained by electrotransfection of wild yak ear fibroblasts, inoculation onto feeder cells, culture, and selection of clones.
[0015] As a further technical solution of the present invention, the wild yak donor pluripotent stem cells were subjected to OCT4, SOX2, NANOG and SSEA-1 immunofluorescence detection, in vitro embryoid formation experiment and karyotype analysis to verify their pluripotency, three germ layer differentiation ability and chromosome normality.
[0016] As a further technical solution of the present invention, artificial insemination is performed using ordinary bovine semen after superovulation of yaks, and the embryos are flushed on the 3rd to 4th day after insemination, or the early embryos of the yak are obtained through in vitro fertilization; Ten to twenty pluripotent stem cells from the wild yak donor were injected into the early embryos of the yak, cultured for 2 to 3 days to obtain chimeric embryos, and the morphologically well-formed chimeric embryos were transplanted into the uterus of a surrogate cow in estrus at the same time.
[0017] As a further technical solution of the present invention, ear tissue and blood of chimeric offspring are collected, and the somatic cell chimerism rate is identified by donor-specific SNP and STR multiplex PCR. Individuals with a donor signal ratio greater than 5% are identified as chimeric positive. After male chimeras reach sexual maturity, the germline chimerism rate is evaluated by semen analysis or testicular biopsy, and male chimeras with high germline chimerism rates are screened. STR typing was performed using species-specific microsatellite marker multiplex PCR, and PCR detection was performed using the Y chromosome sequence unique to wild yak to identify the donor source of sperm. Sperm from identified wild yak donors will be used for in vitro fertilization, artificial insemination, or cryopreservation.
[0018] The beneficial effects of this invention are: 1. This invention utilizes the natural sterility phenotype of male yak to obtain spermatogenic receptors without gene editing, chemical ablation, or irradiation treatment, fundamentally avoiding the off-target effects, alteration of genetic background, and regulatory uncertainties associated with gene editing.
[0019] 2. This invention uses two methods to share the same natural sterility model, and can flexibly select or implement them in parallel according to the availability of donor materials, thereby improving the success rate and reproducibility.
[0020] 3. This invention transforms living animals into bioreactors that can sustainably produce donor sperm by allowing long-term feeding and repeated semen collection using recipient bulls or chimeric bulls, significantly reducing reliance on wild yak capture and semen cryopreservation.
[0021] 4. The technical solution of this invention is not only applicable to wild yaks, but can also be extended to the protection of germplasm resources of other hybrid sterile (such as mules, lions, tigers, etc.) or naturally sterile large animals. Attached Figure Description
[0022] To more clearly illustrate the technical solutions in this invention or the prior art, the drawings used in the description of the embodiments or the prior art will be briefly introduced below. Obviously, the drawings described below are only for this invention. For those skilled in the art, other drawings can be obtained based on these drawings without creative effort.
[0023] Figure 1 This is a schematic diagram of the method flow of the present invention; Figure 2 This is a schematic diagram showing that no sperm cells were present in the testicular tissue of the male yak of the present invention. Figure 3 This is a schematic diagram illustrating the isolation, enrichment, and testicular injection of wild yak spermatogonial stem cells according to the present invention. Figure 4This is a diagram illustrating the isolation and culture of spermatogonial stem cells according to the present invention. Among them: AC. Testicular tissue processing; D. Cultured for 1 day in a mixed system of SSC and somatic cells, the large round cells are spermatogonial stem cells; E. Cultured for 4 days, the somatic cells adhere to the wall and become spindle-shaped; F and G. Cultured for 9 days, the spermatogonial stem cells form a clonal cluster; H and I. Cultured cells are stained with AKP, the spermatogonial stem cell clusters appear reddish-brown; Figure 5 This image shows HE staining of bovine testicular tissue and immunofluorescence staining of spermatogonial stem cells, as presented in this invention. Figure 6 A schematic diagram of the preparation of chimeras by blastocyst injection according to the present invention; Figure 7 This diagram illustrates the establishment and pluripotency identification of wild yak pluripotent stem cells according to the present invention. Figure 8 This is a graph showing the experimental data of bovine embryo chimerism in this invention; Among them: A. Embryonic mosaic process; B. Chimeric blastocyst diagram. Detailed Implementation
[0024] The present invention will now be described in detail with reference to the accompanying drawings and specific embodiments. For some well-known technologies, those skilled in the art may also use other alternative methods to implement the invention. Moreover, the accompanying drawings are only for more specific description of the embodiments and are not intended to specifically limit the present invention.
[0025] like Figures 1-8 As shown, a method for producing wild yak sperm using a male yak sterility model includes the following steps: Male yaks were selected, and at least two semen analyses, along with testicular ultrasound, reproductive hormone testing, and testicular biopsy histological examinations, were conducted to screen for male yaks with significantly reduced endogenous germ cells or arrested at the spermatogonial or primary spermatocyte stage, intact seminiferous tubule basement membranes, presence of Sertoli and interstitial cells, and no extensive fibrosis. These male yaks were then selected as infertile recipients. Spermatogonial stem cells were isolated, enriched, and cultured from legally obtained wild yak testicular tissue to obtain wild yak donor spermatogonial stem cells. Wild yak embryonic stem cells or induced pluripotent stem cells were prepared and their pluripotency was identified to obtain wild yak donor pluripotent stem cells. Simultaneously, early yaks were obtained through artificial insemination or in vitro fertilization between yaks and ordinary cattle. The wild yak donor spermatogonial stem cells are resuspended in a transplantation buffer and injected into the testes of the male yak infertile recipient via reticulotesticular injection, efferent canaliculus injection, or ultrasound-guided multi-point injection into the testis. This allows the wild yak donor spermatogonial stem cells to complete the spermatogenesis process in the male yak infertile recipient, resulting in a transplanted male yak recipient. Alternatively, the wild yak donor pluripotent stem cells are injected into the early embryos of the yak, and chimeric embryos are obtained through in vitro culture. These chimeric embryos are then transplanted into the uterus of a surrogate cow in estrus at the same time, resulting in the birth of chimeric offspring. The germline chimerism rate of the male chimeras is evaluated to obtain male chimeras with a high germline chimerism rate. Testicular ultrasound, semen analysis, and donor cell tracking were performed on the transplanted male yak recipients, and / or semen was collected after the male chimeras with high germline chimerism reached sexual maturity. The sperm in the collected semen were identified as having donor origin by using STR markers and wild yak Y chromosome-specific markers to obtain identified wild yak donor sperm.
[0026] Example 1 Spermatogonial stem cell transplantation route S1. Male yaks aged 12–60 months, in good condition and free from infectious diseases were selected as candidates. Semen analysis was performed using electrostimulation semen collection or artificial vaginal method, with two consecutive examinations at an interval of 7–30 days. Male yaks that showed azoospermia or severe oligospermia in both examinations, with a sperm density of less than 1×10^6 / mL, were included in the candidate range.
[0027] Testicular ultrasound was performed on candidate individuals using a 7.5–10 MHz probe to observe testicular parenchymal echogenicity and seminiferous tubule structure. Serum testosterone, luteinizing hormone (LH), and follicle-stimulating hormone (FSH) were detected using radioimmunoassay or chemiluminescence immunoassay. Testicular biopsy was performed under sedation and local anesthesia. The testicular biopsy samples were stained with hematoxylin and eosin (HE) to observe the seminiferous tubule structure, seminiferous epithelial layers, tubular formation, and spermatogenic cell development stages.
[0028] Further immunohistochemical staining was used to detect spermatogonial or undifferentiated spermatogonial markers PLZF, UCHL1 / PGP9.5, or GFRα1; germ cell markers DAZL and DDX4 / VASA; meiotic marker SYCP3; and post-meiotic and spermatogenesis-related markers ACROSIN / ACRV1 and PRM1. Individuals with significantly reduced endogenous germ cells or arrested at the spermatogonial or primary spermatocyte stage, intact seminiferous tubule basement membranes, presence of Sertoli and interstitial cells, and no extensive fibrosis were selected to obtain male yak infertility recipients.
[0029] Wild yak testicular tissue was obtained according to law and transported to the laboratory in PBS containing double antibodies at 4°C. The capsule and blood vessels of the testicular tissue were removed, and the seminiferous tubules were cut into 1-2 mm³. First, digestion was carried out at 37°C with shaking for 30 min using a digestion solution containing 1 mg / mL collagenase IV and 5 μg / mL DNase I. Then, 0.25% trypsin and 1 mg / mL hyaluronidase were added, and digestion was continued at 37°C for 30 min. The mixture was then filtered through a 40 μm sieve to obtain a single-cell suspension.
[0030] Spermatogonial stem cells were enriched from the obtained single-cell suspension. When using differential adhesion, the single-cell suspension was placed in a gelatin-coated culture dish and allowed to adhere for 1.5 hours at 37°C; unadhered cells were then collected. When using immunomagnetic bead sorting, PLZF, UCHL1, or GFRα1 were used as positive markers, and c-KIT negativity was used as a reference indicator for undifferentiated spermatogonia. Percoll density gradient centrifugation or flow cytometry can also be used for spermatogonial stem cell enrichment; these methods can be used alone or in combination.
[0031] The enriched spermatogonial stem cells were placed in a culture medium containing 10% Knockout Serum Replacement, 10% FBS, 20 ng / mL LGDNF, 20 ng / mL bFGF, 20 ng / mL LEGF, 10 ng / mL LLIF, and 10 mg / mL β-mercaptoethanol for short-term expansion at 37°C and 5% CO2. Cell viability was assessed using trypan blue staining before transplantation, and cells with a viability of at least 85% were selected as wild yak donor spermatogonial stem cells.
[0032] S2. Before transplantation, the male yak infertile recipient was fasted for 12 hours, sedated by intravenous injection of xylazine at a dose of 0.05–0.1 mg / kg, and locally anesthetized with 2% lidocaine. The scrotal area was then disinfected. The wild yak donor spermatogonial stem cells were resuspended in transplantation buffer containing 0.04% trypan blue, and the cell concentration was adjusted to 5 × 10^7 cells / mL.
[0033] Wild yak donor spermatogonial stem cells were introduced into the testes of male yak infertile recipients using one of the following methods: testicular reticulum injection, efferent ductule injection, or ultrasound-guided multi-point injection into the testis. When using testicular reticulum injection, the injection needle was inserted into the mediastinum region of the testis under ultrasound guidance, with 0.5–1 mL injected into each testis. When using efferent ductule injection, the efferent ductules were surgically exposed before microinjection. When using ultrasound-guided multi-point injection into the testis, 3–5 injection points were set up on each testis, with 50–200 μL injected into each point.
[0034] After the injection, male yak infertile recipients were intramuscularly injected with penicillin and streptomycin for 3 consecutive days, and analgesia was managed with flunixin meglumine. After transplantation, male yak recipients were obtained, and the spermatogonial stem cells from wild yak donors were implanted in their testes and completed the spermatogenesis process.
[0035] S3, monitoring of male yak recipients post-transplantation was conducted at week 1, month 1, month 3, month 6, and every 3 months thereafter. This included measuring testicular volume changes using testicular ultrasound, collecting and analyzing semen, and detecting serum testosterone, LH, and FSH. When wild yak donor spermatogonial stem cells carried fluorescent markers, donor cells were tracked using semen fluorescence detection or tissue section fluorescence detection. The first appearance of wild yak donor sperm was expected 3–6 months post-transplantation.
[0036] When sperm was detected in the semen of the male yak recipient after transplantation, STR typing was performed using species-specific microsatellite marker multiplex PCR, and PCR detection was performed using the Y chromosome sequence unique to wild yaks. When the sperm carried the genetic markers of the wild yak donor, it was determined that the wild yak donor spermatogonial stem cells had completed donor-derived spermatogenesis in the testes of the male yak infertile recipient, thus obtaining wild yak donor-derived sperm.
[0037] Example 2 Embryonic mosaic pathway S1. Wild yak pluripotent stem cells were obtained from embryonic stem cells or induced pluripotent stem cells. For embryonic stem cell preparation, wild yak clonal blastocysts (days 7-9) were harvested, the zona pellucida was removed, and the embryos were seeded into 12-well culture plates coated with feeder cells. The culture medium was changed daily, and the cells were cultured for approximately 15 days. The proliferators were then dissociated using TrypL™ Express and reseeded into 12-well culture plates coated with fresh feeder cells, and cultured for approximately 5 more days to obtain typical stem cell clones.
[0038] The established wild yak nuclear transfer embryonic stem cells were cultured in bEPSC medium, with the culture medium changed daily and passaged every 3 days at a ratio of 1:6. The bEPSC medium consisted of 48.5 mL mTeSR™1, 0.5 mL 100× penicillin-streptomycin, 0.1 mM 2-mercaptoethanol, 1 μM CHIR99021, 0.3 μM WH-4-023, 5 μM XAV939 or 5 μM MIWR-1, 50 μg / mL vitamin C, 10 ng / mL LIF, and 20.0 ng / mL Activin A.
[0039] To prepare induced pluripotent stem cells, P3 generation wild yak ear marginal fibroblasts were used. Electroporation was performed using a Lonza 4D electroporator with P3 reagents and the CZ167 program. The total amount of DNA used for electroporation was 6.0 μg, including 4 μg PB–TRE-hOMSK, 1.0 μg PB–EF1a–transposase, and 1.0 μg PB–EF1a–rTTA.
[0040] After electroporation, cells were seeded onto feeder cells and cultured in N2B27 medium supplemented with 10 ng / mL LIF, 50 μg / mL vitamin C, 10 ng / mL bFGF, 2 μM MA8301, 3 μM CHIR99021, and 1 μg / mL LDox. The medium was changed every two days. Cell clones were picked on days 15–20 of culture and maintained in N2B27 medium supplemented with DOx and small molecule inhibitors.
[0041] Immunofluorescence was used to detect OCT4, SOX2, NANOG, and SSEA-1. The differentiation capacity of the three germ layers was verified by in vitro embryoid formation experiments, and karyotype analysis was performed to confirm normal chromosomes, thus obtaining pluripotent stem cells from wild yak donors.
[0042] To prepare early hybrid yak embryos, superovulation is performed on yaks, artificial insemination is carried out using ordinary bovine semen, and embryo flushing is performed on the 3rd to 4th day after insemination to obtain early hybrid yak embryos; or early hybrid yak embryos can be obtained through in vitro fertilization.
[0043] S2. The early hybrid yak embryo was fixed with a fixation needle with an outer diameter of about 120 μm, so that the inner cell mass was located on one side of the field of view. 10 to 20 wild yak donor pluripotent stem cells were aspirated with an injection needle with an inner diameter of 10 μm. After piercing the zona pellucida, the wild yak donor pluripotent stem cells were injected into the early hybrid yak embryo.
[0044] The injected embryos were cultured in a medium for 2-3 days. Some embryos were vitrified and frozen, while others were subjected to chimeric testing to obtain chimeric embryos. Morphologically sound chimeric embryos were selected, and 1-2 chimeric embryos were transferred to the uterus of each surrogate cow in estrus. Pregnancy was monitored with ultrasound until full-term delivery, yielding chimeric offspring.
[0045] Ear tissue and blood were collected from chimeric offspring, and DNA was extracted. Donor-specific SNPs and STR multiplex PCR were used for detection, and the donor signal percentage was calculated. When the donor signal percentage was greater than 5%, the corresponding individual was identified as chimeric positive.
[0046] After male chimeras reach sexual maturity, semen is collected and sperm DNA is extracted. The proportion of donor-derived sperm is calculated using donor-specific SNPs and STR multiplex PCR. Alternatively, testicular biopsy is performed on male chimeras, and donor-specific tests are performed on tissue sections to evaluate the germline chimerism rate and screen for male chimeras with high germline chimerism rates.
[0047] S3, semen was collected periodically from sexually mature male chimeras with high germline chimerism. STR typing was performed using species-specific microsatellite marker multiplex PCR, and PCR detection was performed using the Y chromosome sequence specific to wild yak to identify the donor source of sperm in the semen. Sperm containing wild yak donor genetic markers were considered wild yak donor sperm.
[0048] Example 3 The identification and application of donor sperm are as follows: Identification methods: (a) STR typing—species-specific microsatellite marker multiplex PCR; (b) Y chromosome markers—PCR detection of Y chromosome sequences unique to wild yaks; Applications: After density, motility and morphology analysis, donor sperm is used for in vitro fertilization, artificial insemination, cryopreservation (conventional bovine semen freezing procedure) and bank establishment; the obtained embryos or offspring are further genetically identified to confirm the donor background.
[0049] Example 4 Positive control: Wild yak spermatogonial stem cells from the same source were transplanted into the testes of immunodeficient mice or NANOS2 gene knockout mice to verify that wild yak donor spermatogonial stem cells themselves have the ability to produce sperm. Negative control: Wild yak donor spermatogonial stem cells were transplanted into the testes of ordinary bulls with normal spermatogenesis function to observe whether endogenous germ cells competitively inhibited the colonization of donor cells; Blank control: Semen analysis was continuously performed on male yak yaks that did not receive spermatogonial stem cell transplantation to confirm that the male yak infertility phenotype remained stable throughout the feeding cycle.
[0050] This invention encompasses any substitutions, modifications, equivalent methods, and solutions made within the spirit and scope of this invention. To provide the public with a thorough understanding of this invention, specific details are described in detail in the following preferred embodiments; however, those skilled in the art will fully understand the invention even without these details. Furthermore, to avoid unnecessary misunderstanding of the essence of this invention, well-known methods, processes, procedures, components, and circuits are not described in detail.
[0051] The above description is only a preferred embodiment of the present invention. It should be noted that for those skilled in the art, several improvements and modifications can be made without departing from the principle of the present invention, and these improvements and modifications should also be considered within the scope of protection of the present invention.
Claims
1. A method for producing wild yak sperm using a male yak sterility model, characterized in that, Includes the following steps: Male yak were screened for endogenous germ cell development arrest and intact seminiferous tubule basement membrane, Sertoli cells, and interstitial cells through semen analysis, testicular ultrasound, reproductive hormone testing, and testicular biopsy. Male yak infertility recipients were obtained, and wild yak donor spermatogonial stem cells and wild yak donor pluripotent stem cells were prepared. The spermatogonial stem cells from the wild yak donor were injected into the testes of the male yak infertile recipient to obtain a transplanted male yak recipient. The pluripotent stem cells from the wild yak donor were injected into early hybrid yak embryos, and male chimeras were obtained through culture and embryo transfer. Semen was collected from the transplanted male yak recipient and male chimera. The donor source of the sperm was identified using STR markers and wild yak Y chromosome-specific markers, and wild yak donor sperm was obtained.
2. The method for producing wild yak sperm using a male yak sterility model according to claim 1, characterized in that, The screening of male yak sterility recipients includes: Male yaks aged 12–60 months, in good condition and free from infectious diseases were selected, and two semen analyses were performed at intervals of 7–30 days to screen for individuals with azoospermia or sperm density less than 1×10^6 / mL. The individuals underwent testicular ultrasound, reproductive hormone testing, and testicular biopsy to screen for individuals with intact seminiferous tubule basement membranes, presence of Sertoli cells and interstitial cells, a significant reduction in endogenous germ cells or arrest at the spermatogonial or primary spermatocyte stage, and no extensive fibrosis.
3. The method for producing wild yak sperm using a male yak sterility model according to claim 1, characterized in that, The preparation of the wild yak donor spermatogonial stem cells includes: After removing the capsule and blood vessels from the testicular tissue of wild yak, the seminiferous tubules were cut into small pieces and digested in two steps, successively with digestion solutions containing collagenase IV and DNase I, and digestion solutions containing trypsin and hyaluronidase. The resulting single-cell suspension was filtered. Spermatogonia were enriched using one or more of the following methods: differential adhesion, Percoll density gradient centrifugation, immunomagnetic bead sorting, or flow cytometry. The suspension was then expanded in a short period of time, and cells with a viability of 85% were selected for transplantation.
4. A method for producing wild yak sperm using a male yak sterility model according to claim 1, characterized in that, The spermatogonial stem cells from the wild yak donor were resuspended in a transplantation buffer containing 0.04% trypan blue, and the cell concentration was adjusted to 5×10^7 cells / mL. The cells were then introduced into the testes of the male yak infertile recipient via injection into the testis reticulum, injection into the efferent canaliculus, or ultrasound-guided multi-point injection into the testis parenchyma. The injection volume for testicular reticulum injection is 0.5–1 mL per side. For ultrasound-guided multi-point injection of testicular parenchyma, 3–5 injection points are set on each side, and 50–200 μL is injected at each injection point.
5. A method for producing wild yak sperm using a male yak sterility model according to claim 1, characterized in that, Testicular ultrasound, semen collection and analysis, donor cell tracking, and serum testosterone, luteinizing hormone, and follicle-stimulating hormone (FSH) tests were performed on the male yak recipients at week 1, month 1, month 3, month 6, and every 3 months thereafter.
6. A method for producing wild yak sperm using a male yak sterility model according to claim 1, characterized in that, The wild yak donor pluripotent stem cells are embryonic stem cells or induced pluripotent stem cells; the embryonic stem cells are obtained by removing the zona pellucida of wild yak cloned blastocysts on days 7 to 9, inoculating them onto feeder cells, culturing them, dissociating the proliferators, and re-inoculating them. The induced pluripotent stem cells were obtained by electrotransfection of wild yak ear fibroblasts, inoculation onto feeder cells, culture, and selection of clones.
7. A method for producing wild yak sperm using a male yak sterility model according to claim 6, characterized in that, The pluripotent stem cells from the wild yak donor were subjected to OCT4, SOX2, NANOG and SSEA-1 immunofluorescence detection, in vitro embryoid formation experiment and karyotype analysis to verify their pluripotency, tri-germ layer differentiation ability and chromosome normality.
8. A method for producing wild yak sperm using a male yak sterility model according to claim 1, characterized in that, The yak early embryos were obtained by artificial insemination with ordinary bovine semen after superovulation in yaks, and embryo flushing was performed on the 3rd to 4th day after insemination, or by in vitro fertilization. Ten to twenty pluripotent stem cells from the wild yak donor were injected into the early embryos of the yak, cultured for 2 to 3 days to obtain chimeric embryos, and the morphologically well-formed chimeric embryos were transplanted into the uterus of a surrogate cow in estrus at the same time.
9. A method for producing wild yak sperm using a male yak sterility model according to claim 1, characterized in that, Ear tissue and blood were collected from chimeric offspring. Somatic cell chimerism rate was identified by donor-specific SNP and STR multiplex PCR. Individuals with a donor signal ratio greater than 5% were identified as chimeric positive. After male chimeras reach sexual maturity, the germline chimerism rate is evaluated by semen analysis or testicular biopsy, and male chimeras with high germline chimerism rates are screened. STR typing was performed using species-specific microsatellite marker multiplex PCR, and PCR detection was performed using the Y chromosome sequence unique to wild yak to identify the donor source of sperm. Sperm from identified wild yak donors will be used for in vitro fertilization, artificial insemination, or cryopreservation.
10. An application of producing wild yak sperm using a male yak sterility model, characterized in that, The method includes the method for producing wild yak sperm using a male yak sterility model as described in any one of claims 1-9.
